Turkish Version of Nijmegen Questionnaire
Launched by HACETTEPE UNIVERSITY · Feb 2, 2020
Trial Information
Current as of April 26, 2025
Completed
Keywords
ClinConnect Summary
Nijmegen Questionnaire allows to assess and identify respiratory symptoms and dysfunction, and to assess unexplained respiratory symptoms and symptoms of hyperventilation syndrome. Determining whether Turkish version of Nijmegen Questionnaire is a valid and reliable tool in asthmatic individuals will guide researchers for further studies on identifying appropriate treatment approaches for the patient and developing different treatment strategies. Hyperventilation syndrome is a recognized form of respiratory dysfunction associated with biochemical factors. Hyperventilation syndrome is define...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Having mild to moderate clinically stable asthmatic patients
- • Being able to cooperate
- • Being 18 years old or older
- Exclusion Criteria:
- • Having severe orthopedic, neurological, cardiovascular disorders or cognitive problems
- • Unable to cooperte
About Hacettepe University
Hacettepe University is a leading research institution in Turkey, renowned for its commitment to advancing medical science and healthcare through innovative clinical research. With a strong emphasis on interdisciplinary collaboration, the university supports a wide range of clinical trials aimed at improving patient outcomes and developing new therapeutic approaches. Hacettepe University is dedicated to maintaining the highest ethical standards and regulatory compliance in its research endeavors, fostering an environment that promotes scientific excellence and contributes to the global body of medical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ankara, , Turkey
Patients applied
Trial Officials
Deniz Inal-Ince, Prof
Study Director
Hacettepe University
Gul Karakaya, Prof
Principal Investigator
Hacettepe University
Aslihan Cakmak, MSc
Principal Investigator
Hacettepe University
Senem Simsek, MSc
Principal Investigator
Hacettepe University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials